Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2018 / Cilt: 23 - Sayı: 1

Evaluation of Dermatological Findings in Diabetic Foot Syndrome

Diyabetik Ayak Sendromunda Dermatolojik Bulgularının Değerlendirilmesi

Pages
8–14
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This will help reduce morbidity and mortality which can cause high economic costs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Skin findings in diabetic patients are not rare.
📊
Key Findings & Data:Materials and Methods: A total of 241 patient files followed in the Diabetic Foot Council of Ege University Medical Faculty with the diagnosis of DFS were examined.
💡
Conclusion & Impact:This will help reduce morbidity and mortality which can cause high economic costs.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Skin findings in diabetic patients are not rare. Diabetic Foot Syndrome (DFS) is associated with a high risk of morbidity and mortality. The purpose of this retrospective study is to evaluate the causal relationships of skin findings of DFS patients and to identify the complications that may develop early and to direct them for treatment. Materials and Methods: A total of 241 patient files followed in the Diabetic Foot Council of Ege University Medical Faculty with the diagnosis of DFS were examined. Data on gender, age, diabetes type and duration, HbA1c levels, presence and type of infection, Wagner’s classification, and skin findings of the patients were recorded. These patients were assessed by dermatologists, who were members of the Council, and their findings were recorded. Results: In terms of frequency, 193 (80.1%) patients had xerosis, 80 (33.2%) had plantar hyperkeratosis, 54 (22.4%) had fissure, 55 (22.8%) had maceration and desquamation between toes, 46 (19.1%) had callus formation, 8 (3.3%) had diabetic dermopathy, and 2 (0.8%) had diabetic bulla. In terms of foot deformities, 32 patients (13.3%) had deformation in toes, 89 (36.9%) had claw foot, 38 (15.8%) had hammer/claw toes, 32 (13.3%) had acromegalic finger, 23 (9.5%) had hallux valgus, and 22 (9.1%) had Charcot deformity. According to Wagner classification; 18 (%7.5) patients were Stage 1, 66 (%27.4) were Stage 2, 69 (%28.6) were Stage 3, 64 (%26.6) were Stage 4, and 24 (%10) were Stage 5. In terms of infection, 67 (%27.8) patients had mild infection, 114 (%47.3) had intermediate infection and 60 (%24.9) had severe infection. On time of admission, 114 (%47.3) patients had osteomyelitis but 127 (%52.7) did not. Conclusion: The appearance of skin findings in a diabetic patient indicates the need for more strict patient care and the need for proper foot care. Patients with DFS should be evaluated together with other skin findings on the foot which may prevent complications to occur thanks to early diagnosis and treatment. This will help reduce morbidity and mortality which can cause high economic costs.

Özet

Giriş: Diyabetik hastalarda dermatolojik bulgular yaygın olarak görülür. Diyabetik ayak sendromu yüksek mortalite ve morbiditesi olan bir durumdur. Bu retrospektif çalışmada diyabetik ayak sendromu olan hastaların deri bulgularının sebep-sonuç ilişkilerini değerlendirmek, gelişebilecek komplikasyonları erken dönemde tanımak ve tedavi için doğru yönlendirmek amaçlanmıştır. Materyal ve Metod: Ege Üniversitesi Tıp Fakültesi Diyabetik Ayak Konseyinde takip ettiğimiz toplam 241 diyabetik ayak sendromlu hastanın dosyası incelendi. Hastaların cinsiyet, yaş, diyabet tipi ve süresi, HBA1c düzeyleri, infeksiyon varlığı ve tipi ile ülserlerinin Wagner sınıflaması ve deri bulgularından elde edilen veriler kaydedildi. Bu hastalar konseyin üyeleri olan dermatologlar tarafından değerlendirilip bulguları belirlendi. Bulgular: Hastalarda sıklık sırasına göre; 193 (%80.1) hastada kserozis, 80 (%33.2) hastada plantar hiperkeratoz, 54 (%22.4) hastada fissür, 55 (%22.8) hastada ayak parmak arasında maserasyon, 46 (%19.1) hastada kallus formasyonu, 8 (%3.3) hastada diyabetik dermopati ve 2 (%0.8) hastada diyabetik bül saptandı. Hastalarda mevcut ayak deformitelerine bakıldığında; 32 (%13.3) hastada ayak parmaklarında deformasyon, 89 (%36.9) hastada pençe ayak, 38 (%15.8) hastada çekiç parmak, 32 (%13.3) hastada akromegalik parmak, 23 (%9.5) hastada halluks valgus ve 22 (%9.1) hastada Charcot deformitesi saptandı. Ülserler Wagner sınıflamasına göre; 18 (%7.5) hastada Evre 1, 66 (%27.4) hastada Evre 2, 69 (%28.6) hastada Evre 3, 64 (%26.6) hastada Evre 4 ve 24 (%10) hastada Evre 5 olarak sınıflandırıldı. Altmış yedi (%27.8) hastada hafif infeksiyon, 114 (%47.3) hastada orta şiddette infeksiyon ve 60 (%24.9) hastada ciddi infeksiyon mevcuttu. Başvuru anında 114 (%47.3) hastada osteomiyelit saptanırken, 127 (%52.7) hastada saptanmadı. Sonuç: Diyabetli bir hastada deri bulgularının görülmesi daha sıkı hasta kontrolü gerekliliğini ve uygun ayak bakımı ihtiyacını göstermektedir. Diyabetik ayak sendromlu hastaların ayaktaki diğer deri bulgularıyla birlikte değerlendirilmesi erken tanı ve tedavi ile komplikasyon gelişmesini önleyecektir. Bu değerlendirme sonucu yüksek ekonomik maliyetlere neden olurken morbidite ve mortalitelerin azaltılmasını sağlayacaktır.

🔖

Cite This Article

KAYAŞ, Y., SAĞDUYU, İ. E., UYSAL, S., ŞİMŞİR, I. Y., ÖZTÜRK, A. M., TAŞBAKAN, M. I., ÇETİNKALP, Ş., ARDA, B., ÜNAL, İ. (2018). Evaluation of Dermatological Findings in Diabetic Foot Syndrome. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 23 - Sayı: 1, 8–14. https://ajindex.com/articles/224451

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Inzucchi SE, Shervin RS. Type 1 diabetes mellitus. In: Goldman L, Schafer AI (eds). Goldman’s Cecil Medicine. 24th ed. Philadelphia: Saunders, 2012:1683-700.
  2. Ibrahim A, Jude E, Langton K, Martinez-De Jesus F, Harkless L, Gawish H, et al. IDF clinical practice recommendations on the diabetic foot – 2017. A guideline for healthcare professionals [Internet]. International Diabetes Federation 2017:1- 70. Chand G, Mishra AK, Kumar S, Agarwal A. Diabetic foot. Clin Queries Nephrol 2012;1:144-50.
  3. Orhan B, Bahçecik N. Technology in diabetes and diabetic foot education-mobile education. J Acad Res Nurs 2017;3:101-8.
  4. Ahmed I, Goldstein B. Diabetes mellitus. Clin Dermatol 2006;24:237-46.
  5. Behm B, Schreml S, Landthaler M, Babilas P. Skin signs in diabetes mellitus. J Eur Acad Dermatol Venereol 2012;26:1203- 11. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJG, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012;54:132-73.
  6. Levy L, Zeichner JA. Dermatologic manifestation of diabetes. J Diabetes 2012;4:68-76.
  7. Wani MA, Hassan I, Hayat M, Ahmed QM, Bhat MH. Cutaneous manifestations of diabetes mellitus: a hospital based study. Egypt Dermatol Online J 2009;5:4-9.
  8. Bhat Y, Gupta V, Kudyar RP. Cutaneous manifestations of diabetes mellitus. Int J Diabetes Dev 2006;26:152-5.
  9. Shahzad M, Al Robaee A, Al Shobaili HA, Alzolibani AA, Al Marshood AA, Al Moteri B. Skin manifestations in diabetic patients attending a diabetic clinic in the qassim region, Saudi Arabia. Med Princ Pract 2011;20:137-41.
  10. Gkogkolou P, Bohm M. Skin disorders in diabetes mellitus. J Dtsch Dermatol Ges 2014;12:845-7.
  11. Van Hattem S, Bootsma AT, Thio HB. Skin manifestations of diabetes. Cleve Clin J Med 2008;75:772-87. Piérard GE, Seité S, Hermanns-Lê T, Delvenne P, Scheen A, Piérard-Franchimont C. The skin landscape in diabetes mellitus. Focus on dermocosmetic management. Clin Cosmet Investig Dermatol 2013;6:127-35.
  12. Verma GC, Jain SC, Vyas S, Saluja M, Nyati A, Nehara HR, et al. Prevalence of cutaneous manifestations of diabetes mellitus. J Dent Med Sci 2013;11:41-7. Zimmo SKH. Prevalence of skin manifestations in diabetes mellitus at King Abdulaziz University Hospital. Saudi J Med 2012;2:19-22.
  13. Goyal A, Raina S, Kaushal SS, Mahajan V, Sharma NL. Pattern of cutaneous manifestations in diabetes mellitus. Indian J Dermatol 2010;55:39-41.
  14. Arosi I, Hiner G, Rajbhandari S. Pathogenesis and trea